Platform Versatility & Advantages

NTT’s proprietary MSNs offer a highly tunable drug delivery platform with superior loading capacity, targeted delivery, and enhanced efficacy with milder adverse effects.

The MSN platform enables the development of a range of products for high-impact medical applications, including:

• Cancer

• Neurodegenerative and CNS Disorders

• Ophthalmic / Retinal Diseases (Eyedrop Formulation)

• Genetic and Rare Diseases

• Metabolic and Gastrointestinal Disorders